This inventor holds 2 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: Venatorx Pharmaceuticals, Inc.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Anthony Drager: Innovator in Pharmaceutical Chemistry
Introduction
Anthony Drager is a notable inventor based in Thorndale, PA (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of beta-lactamase inhibitors. With a total of 2 patents, Drager's work is pivotal in advancing antibacterial treatments.
Latest Patents
Drager's latest patents include a citrate coordination complex of an orally-delivered beta-lactamase inhibitor. This invention discloses a compound that is (R)-(2-(3-((((2-ethylbutanoyl)oxy)methoxy)carbonyl)-2-hydroxyphenyl)-1-propionamidoethyl)boronic acid citrate coordination complex, or a pharmaceutically acceptable salt or solvate thereof. Additionally, he has developed methods for treating bacterial infections using this compound in combination with ceftibuten. Another significant patent relates to pharmaceutical compositions containing boron-containing compounds, which serve as inhibitors of beta-lactamase enzymes and as antibacterial agents in conjunction with beta-lactam antibiotics.
Career Highlights
Drager is currently associated with Venatorx Pharmaceuticals, Inc., where he continues to innovate in the pharmaceutical sector. His work focuses on creating effective solutions to combat bacterial resistance, a growing concern in modern medicine.
Collaborations
Throughout his career, Drager has collaborated with esteemed colleagues, including Jodie Hamrick and Timothy Henkel. These partnerships have fostered a collaborative environment that enhances the development of groundbreaking pharmaceutical solutions.
Conclusion
Anthony Drager's contributions to pharmaceutical chemistry, particularly in the realm of beta-lactamase inhibitors, underscore his importance as an inventor. His innovative patents and collaborations reflect a commitment to advancing healthcare solutions.